ARCHIVES

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

This article is from The Cancer Letter archive.

Vol. 03 No. 02 | January 14, 1977

Download PDF Visit The Full Archive

Related Articles

White Heads NIH Legislative Policy Office

March 5, 2010

HHS plans network of smoking cessation quitlines.

February 6, 2004

High Risk Youth Targeted In Concept Ok’d By Advisors

February 8, 1991

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012

Authorizes $2.7 Billion For NCI, 7% Prevention

May 28, 1993

Navelbine+Herceptin: 78% Response In Breast Cancer

November 29, 2002